Abstract
Previous experimental studies show that exposure to noise with high and audible frequencies causes multiple metabolic alterations, such as increased liver glycogen and triglycerides. However, the effect of exposure to sound with lower frequencies, such as high-intensity infrasound (frequency <20 Hz and sound pressure level >90 dB), on the liver lipid content is still unclear. As such, we aimed to study the effect of exposure to high-intensity infrasound of both normal and glucose intolerant rats on the liver lipid content. For this study, 79 wild-type male Wistar rats were randomly divided into two groups: G1, no treatment, and G2, induced glucose intolerance. Each of these two groups was randomly divided in two subgroups: s (animals kept in silence) and i (animals continuously exposed to high-intensity infrasound noise). At three noise-exposure time-points (1, 6 and 12 weeks) the rats were sacrificed, the liver was excised and hepatic lipids extracted. Data analysis was performed using a two-way ANOVA (p = 0.05). No significant effects due to interactions between the several factors exist on the liver lipid content (p=0.077). Moreover, no significant effects due to infrasound exposure (p=0.407) or glucose tolerance status (p=0.938) were observed. Our study shows that continuous exposure to high-intensity infrasound has no influence on the lipid content of the liver of both normal and glucose intolerant animals. This finding reinforces the need for further experimental studies on the physiological effects of infrasound due to its possible hazardous effects on human health.
Keywords: Infrasound, Glucose intolerance, Liver lipids, Liver steatosis, Rat, Environmental health, Diabetes, Obesity, Hepatobiliary system, Endocrine system, Metabolic disorder, Endocrinology
Infrasound; Glucose intolerance; Liver lipids; Liver steatosis; Rat; Environmental health; Diabetes; Obesity; Hepatobiliary system; Endocrine system; Metabolic disorder; Endocrinology
1. Introduction
Noise pollution is an important environmental and occupational risk factor known to cause several adverse effects on human health beyond the auditory system [1]. In Europe, noise was estimated the third environmental risk factor with major impact on public health [2]. The World Health Organization (WHO) Regional Office for Europe has acknowledged that low-frequency noise, below 200 Hz (including infrasound), represents an environmental problem and that research should focus on its outcomes [3].
In previous experimental studies, metabolic abnormalities such as glucose intolerance, insulin resistance, fasting hyperglycemia, dyslipidemia and alterations in insulin signaling in the skeletal muscle have been identified as a consequence of noise exposure with frequencies higher than 200 Hz [4, 5, 6]. Cui et al. [4] also referred increased levels of glycogen and triglycerides in the liver of noise-exposed rats that may lead to non-alcoholic fatty liver disease, a marker of metabolic dysfunction and risk factor for liver fibrosis, cirrhosis and cancer [7, 8]. This accumulation of lipids in visceral fat is a key player in metabolic derangement and an important risk factor for type 2 diabetes and metabolic syndrome [9]. However, it is still unknown whether exposure to lower frequencies, namely high-intensity infrasound (frequency <20 Hz and sound pressure level >90 dB), induces the same changes in hepatic lipid content.
Therefore, we aimed to investigate if exposure to high-intensity infrasound induces changes in the liver lipids on both normal and glucose intolerant rats and to define the contribution of each of these factors to such outcome.
2. Material and methods
2.1. Animals
Experimental design and planning were performed with full compliance to the PREPARE guidelines [10]. When applied, animal procedures were approved by the Portuguese National Authority for Animal Health (project nº 204/2017). All handling and care of the animals were performed by authorized researchers (accredited by FELASA Category C) and was done in accordance with the EU Comission on Animal Protection for Experimental and Scientific Purposes (2010/63/EU) and with the Portuguese legislation for the same purpose (DL 113/2013).
In compliance with the 3Rs principles [11], this study shares data and resources with a larger study of infrasound-induced pancreatic fibrosis, for which the sample size was estimated based on a priori power analysis using G∗Power 3 software [12] for a minimum statistical power of 80% (unpublished data). Thus, tissue samples were collected from randomly selected seventy-nine animals of the original sample of one hundred and fifty-six wild-type male Wistar rats acquired from Charles River Laboratories (Saint-Germain-sur-l’Arbresle, France), aged 11 weeks and weighing 375.95g ± 18.29g. Only male rats were included in order to avoid uncertain sex-dependent differences on the outcomes. They were housed in conventional cages, two animals per cage, with a 12h light/dark cycle (lights on at 8am) and had free access to food (standard rat chow) and water.
After a one-week acclimation period the original sample of one hundred and fifty-six animals were randomly assigned using a free access online software [13] into two groups: G1 (no treatment) and G2 (glucose intolerance). For this study, 39 animals were randomly selected from G1 and 40 animals randomly selected from G2 (Table 1).
Table 1.
Number of animals per experimental group and mean values and standard deviation for glycemia at intraperitoneal glucose tolerance test 2h timepoint, expressed as milligrams per deciliter (mg/dL), for each experimental group of normal (G1) and glucose intolerant (G2) animals, either kept in silence (s) or exposed to high-intensity infrasound (i).
G1 (n = 39) |
G2 (n = 40) |
||||
---|---|---|---|---|---|
123.59 ± 18.39 | 158.05 ± 30.58 | ||||
G1s (n = 19) | 1 wk (n = 6) | 138.25 ± 13.77 | G2s (n = 20) | 1 wk (n = 6) | 148.63 ± 45.54 |
6 wks (n = 6) | 154.25 ± 20.45 | 6 wks (n = 7) | 154.75 ± 17.43 | ||
12 wks (n = 7) | 143.75 ± 21.31 | 12 wks (n = 7) | 168.00 ± 25.04 | ||
G1i (n = 20) | 1 wk (n = 6) | 156.63 ± 27.79 | G2i (n = 20) | 1 wk (n = 6) | 151.00 ± 17.57 |
6 wks (n = 7) | 142.14 ± 20.75 | 6 wks (n = 7) | 152.17 ± 22.34 | ||
12 wks (n = 7) | 141.83 ± 14.23 | 12 wks (n = 7) | 157.00 ± 11.45 |
2.2. Glucose intolerance
Glucose intolerance was induced through a high-fat diet (D12492 diet, Research Diets) and the administration of low-dose streptozotocin (HFD/STZ rat model) because this model is considered to mimic the human disease [14]. The protocol for glucose intolerance was performed as described by Furman [15]. In short, animals were fed a high-fat diet, with 60% of calories coming from fats, for 3 weeks. After this period STZ (STZ, Sigma) 40 mg/kg was prepared in a sodium citrate buffer 50mM, pH4.4, and was administered intraperitoneally after a fasting period of 6–8 h, with unlimited access to water.
Glucose intolerance was confirmed through an intraperitoneal glucose tolerance test (G2 animals with mean value for glycemia 158.05 mg/dL ± 30.58 mg/dL at 2h timepoint Vs. G1 animals with mean value for glycemia 123.59 mg/dL ± 18.39 mg/dL at 2h timepoint, Table 1 and supplemental material) following the protocol established by Ayala et al. [16]. G1 and G2 animals were then fed standard rat chow and were randomly divided in two subgroups each (Table 1): G1s (no treatment, silence, 19 animals), G1i (no treatment, infrasound, 20 animals), G2s (glucose intolerance, silence, 20 animals) and G2i (glucose intolerance, infrasound, 20 animals). Animals from each of the four groups were randomly divided into three infrasound exposure timepoints and euthanized after 1, 6 and 12 weeks of exposure (animals were randomly distributed as stated in Table 1). Before euthanasia, glucose intolerance was again confirmed through an intraperitoneal glucose tolerance test (mean values for glycemia at 2h timepoint and standard deviation for each experimental group in Table 1 and supplemental material) following the protocol established by Ayala et al. [16].
2.3. Infrasound exposure
Infrasound exposure was performed as previously described by Oliveira et al. [17]. Animal cages were placed in a soundproofed room, measuring 217 × 211 × 195 cm, in front of a noise generator consisting of a subwoofer that reproduced a continuous (24h/day) sound signal, previously recorded in a cotton-mill room from a large textile factory of Northern Portugal. This sound signal was processed offline, applying LabVIEW and Matlab systems.
With the objective of creating a strong subsonic acoustic field in the room, a pseudo-random waveform in the 2-Hz to 20-Hz decade band was filtered from the recorded sound signal with Matlab based on a bandpass-filtered 30-s maximum length sequence segment. The waveform was used to excite an array of two infinite baffles mounted 18-in. 300-W-rated magnetodynamic subwoofers, by means of a 2×600-Wheavy-duty quasi-dc voltage output audio power amplifier. Subsequently, with the aim of exploiting as much as possible the available subwoofers dynamic range at this frequency range with an acceptable amplitude distortion, the waveform was iteratively nonlinearly treated with moderate compression expansion and further filtering (in order to reduce the crest factor to approximately 2.0 times). The total sound pressure level and the spectral characteristics of the resulting acoustic pressure waveform were monitored, and the results were an average sound pressure level of 120 dB in the 2–20 Hz with a tolerance of ±3 dB in a 30 s time window in the entire compartment. As to the spectral boundedness of the produced sound field the result was 80 dB total out-of-band average sound pressure level (-40 dB lower). Groups not exposed to infrasound were kept in a similar room but in silence.
2.4. Liver lipid content
At the respective timepoint, all rats were euthanized by inhalation of carbon dioxide. Liver was excised and hepatic lipids were extracted according to the protocol established by Folch et al. [18]. Samples of approximately 15mg were obtained and homogenized in a chloroform/methanol solution (v/v, 2:1), shaken for 20 min at room temperature and then centrifuged at 1200 rpm, at 4 °C, for 10 min. Small volumes of 0.9% NaCl were added and centrifuged to separate both phases. The lower phase was evaporated with nitrogen and dried at 100 °C with weighting every 10 min until weight stabilized. Results are expressed as milligrams of lipids per gram of liver.
2.5. Statistical analysis
A univariate general linear model (two-way ANOVA), with dependent variable defined by lipid content and two nominal main factors defined by infrasound exposure and glucose tolerance status, was used for data analysis. The assumptions of normal distribution and variance homogeneity of the lipid content distribution were checked using the Shapiro-Wilk test and the Levene test, respectively. Data analysis was performed with the software IBM SPSS Statistics for Windows, version 26 (IBM Corp., Armonk, NY, USA), at the 5% significance level (p = 0.05).
3. Results
The mean values and standard deviation of lipid content in the liver are illustrated on Table 2 and in Figure 1. The effect of age as a covariable on hepatic lipid content was discarded due to a non-significant Pearson correlation between both variables (r = 0.137, p = 0.228). Despite this non-significant correlation, the duration of noise exposure was included as covariable in a general linear model with two main factors (high-intensity infrasound exposure and glucose tolerance status), after validation of the assumption of homogeneity of variance (Levene test, p = 0.460). It should be noted that the assumption of normal distribution of lipid content hold, except in one subgroup (Shapiro-Wilk test, p = 0.026), in which however no severe symmetry was detected. Furthermore, no significant interaction between the covariate and the main factors included in the model was observed. The results show that no significant effects due to interactions between the several factors exist on the liver lipid content (p = 0.077). Moreover, no significant effects due to high-intensity infrasound exposure (p = 0.407) or glucose tolerance status (p = 0.938) were observed.
Table 2.
Mean values and standard deviation for liver lipid content, expressed as milligrams of lipids per gram of liver in normal (G1) and glucose intolerant (G2) animals, either kept in silence (s) or exposed to high-intensity infrasound (i) at different timepoints. No significant effects on the liver lipid content were observed, due to interactions between factors (p = 0.077), infrasound exposure (p = 0.407) or glucose tolerance status (p = 0.938).
Group | Timepoint of sacrifice | Liver Lipid Content | |
---|---|---|---|
No treatment (G1) | G1s | week 1 | 54.78 (±7.91) |
week 6 | 49.00 (±8.23) | ||
week 12 | 59.00 (±8.58) | ||
G1i | week 1 | 54.13 (±19.91) | |
week 6 | 49.50 (±5.65) | ||
week 12 | 51.71 (±9.52) | ||
Glucose intolerance (G2) | G2s | week 1 | 51.20 (±3.49) |
week 6 | 48.33 (±4.89) | ||
week 12 | 50.40 (±11.06) | ||
G2i | week 1 | 48.00 (±17.09) | |
week 6 | 56.20 (±10.64) | ||
week 12 | 61.00 (±4.65) |
Figure 1.
Liver lipid content of normal (G1) and glucose intolerant rats (G2) kept in silence (s) and exposed to high-intensity infrasound (i) at different timepoints. A non-significant effect on the liver lipid content due to interactions between factors (p = 0.077) was observed, as well as due to glucose tolerance status (p = 0.938) or noise exposure (p = 0.407).
However, and despite not being statistically significant (p = 0.077), our results may suggest the existence of an interaction between factors, that is, that the response to noise exposure with regard to the hepatic fat content depends on the metabolic condition of the animals, which is also suggested by Figure 2. Nevertheless, these conclusions must be considered with caution, in light of the above.
Figure 2.
Comparison of estimated marginal mean values of liver lipid content in relation with noise exposure and glucose tolerance status. No significant effects were observed on the liver lipid content due to interactions between factors (p = 0.077).
4. Discussion
Our study aimed to investigate whether chronic exposure to high-intensity infrasound could trigger metabolic changes in the liver, namely on its lipid content, in both normal and glucose intolerant rats. Our results show that there is no influence from such exposure on this outcome, although in glucose intolerant rats the liver lipid content is slightly increased, which may be due to chance, but also reinforces the need of further evaluations to address if the presence of glucose intolerance may be an additional risk factor for the alterations induced by chronic exposure to high-intensity infrasound.
High-intensity infrasound exposure studies in laboratory animals addressing liver lipid content are scarce since most studies focus on audible noise with higher frequencies [4, 5, 6]. In these studies, an increase in hepatic concentration of glycogen and triglycerides has been described [4]. Several theoretical models for the association between audible noise exposure and metabolic changes have been developed, focusing on the role of noise as a stressor, and as a trigger of the neuroendocrine pathways that promote hyperglycemia, insulin resistance and fat accumulation [19, 20]. Liver steatosis can also result from endoplasmic reticulum stress, through impaired fatty acid oxidation and disturbance of the unfolded protein response [21].
Previous experimental studies support the role of audible noise exposure as a liver stressor [22, 23]. These studies have demonstrated that chronic stress associated with an enriched diet increases the levels of total cholesterol and triglycerides in the liver, as well as hepatic inflammation and oxidative stress [22], aggravating the induced nonalcoholic fatty liver disease from steatosis to steatohepatitis [23].
Infrasound is a mechanical vibration wave with a frequency range below 20 Hz, originated by natural phenomena and man-made sources, such as industrial installations, low-speed machinery and music [24, 25]. Due to its wavelength, infrasound can propagate over very large distances without being reflected or absorbed by obstacles and is hardly attenuated through dissipation [24]. As such, infrasound can induce body vibrations and resonance in body cavities, thus affecting internal systems and organs [26].
There is evidence from high-intensity infrasound exposure studies in laboratory animals that chronic exposure results in proliferation of the connective tissue matrix and collagen fibers in animals; this fibrotic response has been documented in several organs, such as the heart, lung and glands of rats chronically exposed to industrial-type noise [27, 28, 29, 30]. Oliveira et al. [31] documented the same alterations in the liver connective tissue, on centrolobular regions without disruption of the organ architecture, as a result of the exposure to high-intensity infrasound. This is thought to be a response to the body vibrations induced by infrasound and may function as a mechanical stabilizer of the organ [30].
However, there is a common misconception about the inaudibility of infrasound since sounds with lower frequencies can still be heard with an increase of the sound pressure level [24, 26]. Higher pressure levels, as the ones used in our study, can elicit both body vibration and hearing response from the animal model used [32, 33]. As such, we cannot exclude animal stress due to audible noise with subsequent activation of the neuroendocrine pathways. To answer this question, future studies should assess clinical and behavioral signs along with corticosterone, the primary stress hormone in rodents, to examine the stress response of the experimental animal [34].
The major limitation of our study is the number of animals, as the study sample was drawn from an original sample estimated for a larger metabolic experimental study on infrasound-induced pancreatic fibrosis (according to the 3Rs principles), as stated in section 2.1 [11]. On the other hand, the experimental protocol allows the assessment of interactions between other important variables studied. We also considered the effect of aging on our experimental protocol, since lipogenesis and fat accumulation leading to liver steatosis are both part of the natural aging process of the liver [35, 36]. Accordingly, we used age-matched animals, as control groups, and the effect of time as a covariable was discarded due to a non-significant correlation between both variables. We have found a discrete, non-significant increase, of liver lipid in the glucose intolerant rats that may be due to chance. Nevertheless, and although we had 79 animals, future studies should consider the possibility of this additional risk factor for the alterations induced by chronic exposure to high-intensity infrasound.
In summary, our study shows that continuous exposure to high-intensity infrasound has no influence on the liver lipid content of both normal and glucose intolerant animals. Within the limitations of our study, these results reinforce the importance of further research concerning the effects of high-intensity infrasound, a ubiquitous element, on the liver due to its possible hazardous effects on human health.
Declarations
Author contribution statement
Gonçalo Martins Pereira: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.
Sofia Pereira, Madalena Santos: Conceived and designed the experiments; Performed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper.
José Brito: Analyzed and interpreted the data; Wrote the paper. Diamantino Freitas, António Carvalho: Conceived and designed the experiments; Performed the experiments; Wrote the paper.
Artur Águas: Conceived and designed the experiments; Contributed reagents, materials, analysis tools or data; Wrote the paper.
Maria João Oliveira, Pedro Oliveira: Conceived and designed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper.
Funding statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Competing interest statement
The authors declare no conflict of interest.
Additional information
No additional information is available for this paper.
Appendix A. Supplementary data
The following is the supplementary data related to this article:
References
- 1.Basner M., Babisch W., Davis A. Auditory and non-auditory effects of noise on health. Lancet. 2014;383(9925):1325–1332. doi: 10.1016/S0140-6736(13)61613-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hänninen O., Knol A.B., Jantunen M. Environmental burden of disease in Europe: assessing nine risk factors in six countries. Environ. Health Perspect. 2014;122(5):439–446. doi: 10.1289/ehp.1206154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.World Health Organization Regional Office for Europe . 2018. Environmental Noise Guidelines for the European Region.http://www.euro.who.int/__data/assets/pdf_file/0008/383921/noise-guidelines-eng.pdf?ua=1 Retrieved from. [Google Scholar]
- 4.Cui B., Gai Z., She X., Wang R., Xi Z. Effects of chronic noise on glucose metabolism and gut microbiota-host inflammatory homeostasis in rats. Sci. Rep. 2016;6:36693. doi: 10.1038/srep36693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Liu L., Wang F., Lu H. Effects of noise exposure on systemic and tissue-level markers of glucose homeostasis and insulin resistance in male mice. Environ. Health Perspect. 2016;124(9):1390–1398. doi: 10.1289/EHP162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Liu L., Huang Y., Fang C. Chronic noise-exposure exacerbates insulin resistance and promotes the manifestations of the type 2 diabetes in a high-fat diet mouse model. PloS One. 2018;13(3) doi: 10.1371/journal.pone.0195411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Arab J.P., Arrese M., Trauner M. Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu. Rev. Pathol. 2018;13:321–350. doi: 10.1146/annurev-pathol-020117-043617. [DOI] [PubMed] [Google Scholar]
- 8.Benedict M., Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J. Hepatol. 2017;9(16):715–732. doi: 10.4254/wjh.v9.i16.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.González-Muniesa P., Mártinez-González M.A., Hu F.B. Obesity. Nat. Rev. Dis. Primers. 2017;3:17034. doi: 10.1038/nrdp.2017.34. [DOI] [PubMed] [Google Scholar]
- 10.Smith A.J., Clutton R.E., Lilley E., Hansen K.E.A., Brattelid T. PREPARE: guidelines for planning animal research and testing. Lab. Anim. 2018;52(2):135–141. doi: 10.1177/0023677217724823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tannenbaum J., Bennett B.T. Russell and Burch's 3Rs then and now: the need for clarity in definition and purpose. JAALAS. 2015;54(2):120–132. [PMC free article] [PubMed] [Google Scholar]
- 12.Faul F., Erdfelder E., Lang A.G., Buchner A. G ∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods. 2007;39(2):175–191. doi: 10.3758/bf03193146. [DOI] [PubMed] [Google Scholar]
- 13.Suresh K. An overview of randomization techniques: an unbiased assessment of outcome in clinical research. J. Hum. Reprod. Sci. 2011;4(1):8–11. doi: 10.4103/0974-1208.82352. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 14.Kleinert M., Clemmensen C., Hofmann S.M. Animal models of obesity and diabetes mellitus. Nat. Rev. Endocrinol. 2018;14(3):140–162. doi: 10.1038/nrendo.2017.161. [DOI] [PubMed] [Google Scholar]
- 15.Furman B.L. Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 2015;70:5–47. doi: 10.1002/0471141755.ph0547s70. 1-20. [DOI] [PubMed] [Google Scholar]
- 16.Ayala J.E., Samuel V.T., Morton G.J. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model Mech. 2010;3(9-10):525–534. doi: 10.1242/dmm.006239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Oliveira M.J., Monteiro M.P., Ribeiro A.M., Pignatelli D., Águas A.P. Chronic exposure of rats to occupational textile noise causes cytological changes in adrenal cortex. Noise Health. 2009;11(43):118–123. doi: 10.4103/1463-1741.50697. [DOI] [PubMed] [Google Scholar]
- 18.Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957;226(1):497–509. [PubMed] [Google Scholar]
- 19.Recio A., Linares C., Banegas J.R., Díaz J. Road traffic noise effects on cardiovascular, respiratory, and metabolic health: an integrative model of biological mechanisms. Environ. Res. 2016;146:359–370. doi: 10.1016/j.envres.2015.12.036. [DOI] [PubMed] [Google Scholar]
- 20.Münzel T., Sørensen M., Gori T. Environmental stressors and cardio-metabolic disease: part II-mechanistic insights. Eur. Heart J. 2017;38(8):557–564. doi: 10.1093/eurheartj/ehw294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lebeaupin C., Vallée D., Hazari Y., Hetz C., Chevet E., Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 2018;69(4):927–947. doi: 10.1016/j.jhep.2018.06.008. [DOI] [PubMed] [Google Scholar]
- 22.Gao S., Han X., Fu J., Yuan X., Sun X., Li Q. Influence of chronic stress on the compositions of hepatic cholesterol and triglyceride in male Wistar rats fed a high fat diet. Hepatol. Res. 2012;42(7):686–695. doi: 10.1111/j.1872-034X.2011.00961.x. [DOI] [PubMed] [Google Scholar]
- 23.Fu J.H., Sun H.S., Wang Y., Zheng W.Q., Shi Z.Y., Wang Q.J. The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male Wistar rats. Dig. Dis. Sci. 2010;55(8):2227–2236. doi: 10.1007/s10620-009-1019-6. [DOI] [PubMed] [Google Scholar]
- 24.Mühlhans J. Low frequency and infrasound: a critical review of the myths, misbeliefs and their relevance to music perception research. Music. Sci. 2017;21(3):267–286. [Google Scholar]
- 25.Reybrouck M., Podlipniak P., Welch D. Music and noise: same or different? What our body tells us. Front. Psychol. 2019;10:1153. doi: 10.3389/fpsyg.2019.01153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Leventhall G. What is infrasound? Prog. Biophys. Mol. Biol. 2007;93(1-3):130–137. doi: 10.1016/j.pbiomolbio.2006.07.006. [DOI] [PubMed] [Google Scholar]
- 27.Antunes E., Oliveira P., Borrecho G. Myocardial fibrosis in rats exposed to low frequency noise. Acta Cardiol. 2013;68(3):241–245. doi: 10.1080/ac.68.3.2983417. [DOI] [PubMed] [Google Scholar]
- 28.Grande N., Águas A.P., Sousa Pereira A., Monteiro E., Castelo Branco N. Morphological changes in the rat lung parenchyma exposed to low frequency noise. Aviat. Space Environ. Med. 1999;70(Suppl. 3):A70–A77. [PubMed] [Google Scholar]
- 29.Lousinha A., Oliveira M.J., Borrecho G. Infrasound induces coronary perivascular fibrosis in rats. Cardiovasc. Pathol. 2018;37:39–44. doi: 10.1016/j.carpath.2018.10.004. [DOI] [PubMed] [Google Scholar]
- 30.Oliveira P., Brito J., Mendes J., Fonseca J., Águas A., Martins dos Santos J. Effects of large pressure amplitude low frequency noise in the parotid gland perivasculo-ductal connective tissue. Acta Med. Port. 2013;26(3):237–242. [PubMed] [Google Scholar]
- 31.Oliveira M.J., Freitas D., Carvalho A.P.O., Guimarães L., Pinto A., Águas A.P. Exposure to industrial wideband noise increases connective tissue in the rat liver. Noise Health. 2012;14(60):227–229. doi: 10.4103/1463-1741.102959. [DOI] [PubMed] [Google Scholar]
- 32.Reynolds R., Li Y., Garner A., Norton J. Vibration in mice: a review of comparative effects and use in translational research. Anim. Model Exp. Med. 2018;1:116–124. doi: 10.1002/ame2.12024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Turner J.G., Parrish J.L., Hughes L.F., Toth L.A., Caspary D.M. Hearing in laboratory animals: strain differences and nonauditory effects of noise. Comp. Med. 2005;55(1):12–23. [PMC free article] [PubMed] [Google Scholar]
- 34.Bekhbat M., Glasper E.R., Rowson S.A., Kelly S.D., Neigh G.N. Measuring corticosterone concentrations over a physiological dynamic range in female rats. Physiol. Behav. 2018;194:73–76. doi: 10.1016/j.physbeh.2018.04.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hunt N.J., Kang S.W.S., Lockwood G.P., Le Couteur D.G., Cogger V.C. Hallmarks of aging in the liver. Comput. Struct. Biotechnol. J. 2019;17:1151–1161. doi: 10.1016/j.csbj.2019.07.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Morsiani C., Bacalini M.G., Santoro A. The peculiar aging of human liver: a geroscience perspective within transplant context. Ageing Res. Rev. 2019;51:24–34. doi: 10.1016/j.arr.2019.02.002. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.